BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 35664436)

  • 1. Interferon Regulatory Factor Family Genes: At the Crossroads between Immunity and Head and Neck Squamous Carcinoma.
    Liu S; Wang Z
    Dis Markers; 2022; 2022():2561673. PubMed ID: 35664436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon regulatory factor transcript levels correlate with clinical outcomes in human glioma.
    Lei J; Zhou MH; Zhang FC; Wu K; Liu SW; Niu HQ
    Aging (Albany NY); 2021 Apr; 13(8):12086-12098. PubMed ID: 33902005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of genetic mechanisms underlying lipid metabolism-mediated tumor immunity in head and neck squamous cell carcinoma.
    Liu S; Wang S; Wang Z
    BMC Med Genomics; 2023 May; 16(1):110. PubMed ID: 37210507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Analysis of Interferon Regulatory Factor Expression: Correlation with Immune Cell Infiltration and Patient Prognosis in Endometrial Carcinoma.
    Lu X; Li R; Ying Y; Zhang W
    Biomed Res Int; 2022; 2022():7948898. PubMed ID: 35993041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients-An Integrated Bioinformatics Approach.
    Gong X; Ren F
    Dis Markers; 2022; 2022():5239033. PubMed ID: 35711568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization and expression analysis of eleven interferon regulatory factors in half-smooth tongue sole, Cynoglossus semilaevis.
    Zhang J; Li YX; Hu YH
    Fish Shellfish Immunol; 2015 May; 44(1):272-82. PubMed ID: 25731919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and prognostic analysis of BGN in head and neck squamous cell carcinoma.
    Zhao L; Liang J; Zhong W; Han C; Liu D; Chen X
    Gene; 2022 Jun; 827():146461. PubMed ID: 35358652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of diagnostic, prognostic value and potential drug treatment of GSDME in head and neck squamous cell carcinoma.
    Hu R; Lu M; She L
    Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4239-4253. PubMed ID: 37204444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
    Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma.
    Chen Y
    Dis Markers; 2022; 2022():6410113. PubMed ID: 35756491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composition and transcription of all interferon regulatory factors (IRFs), IRF1‒11 in a perciform fish, the mandarin fish, Siniperca chuatsi.
    Laghari ZA; Li L; Chen SN; Huo HJ; Huang B; Zhou Y; Nie P
    Dev Comp Immunol; 2018 Apr; 81():127-140. PubMed ID: 29180032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiles of immune cell infiltration in head and neck squamous carcinoma.
    Liang B; Tao Y; Wang T
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
    Chen YJ; Luo SN; Dong L; Liu TT; Shen XZ; Zhang NP; Liang L
    J Transl Med; 2021 Sep; 19(1):379. PubMed ID: 34488791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the Prognostic Value and Clinical Significance of Interferon Regulatory Factors (IRFs) in Colon Adenocarcinoma.
    Yuemaier M; Zhou Z; Zhou Y; Wu C; Li F; Liang X; Kang H; Shen D; Gao F; Lin J
    Med Sci Monit; 2020 Nov; 26():e927073. PubMed ID: 33161410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
    Huang J; Liang B; Wang T
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and methylation of
    Zhao Y; Zhao J; Zhong M; Zhang Q; Yan F; Feng Y; Guo Y
    Front Genet; 2022; 13():982241. PubMed ID: 36204311
    [No Abstract]   [Full Text] [Related]  

  • 18. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
    Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
    Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma.
    Yang Z; Li X; Li J; Su Q; Qiu Y; Zhang Z; Zhang L; Mo W
    Biomed Res Int; 2020; 2020():3962146. PubMed ID: 33083464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma.
    Liu M; Huang L; Liu Y; Yang S; Rao Y; Chen X; Nie M; Liu X
    J Transl Med; 2023 Mar; 21(1):208. PubMed ID: 36941602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.